Clinical and testing protocols for the analysis of epidermal growth factor receptor mutations in East Asian patients with non-small cell lung cancer: A combined clinical-molecular pathological approach

Background: Several randomized phase III studies in advanced stage non-small cell lung cancer (NSCLC) confirmed the superior response rate and progression-free survival of using epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor as first-line therapy compared with chemotherapy in pati...

Full description

Saved in:
Bibliographic Details
Main Authors: Salto-Tellez M., Tsao M., Shih J., Thongprasert S., Lu S., Chang G., Au J., Chou T., Lee J., Shi Y., Radzi A., Kang J., Kim S., Tan S., Yang J.
Format: Journal
Published: 2017
Online Access:https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=80053023140&origin=inward
http://cmuir.cmu.ac.th/jspui/handle/6653943832/42987
Tags: Add Tag
No Tags, Be the first to tag this record!
Institution: Chiang Mai University